ALDH6A1
ALDH6A1 (aldehyde dehydrogenase 6 family member A1, also known as MMSDH) is a mitochondrial methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase. It acts in the catabolism of valine and of pyrimidine-derived compounds handled through beta-alanine. Browse Assay Genie's current range of ALDH6A1 research reagents below, or read on for the biology behind the target.
ALDH6A1 is a malonate and methylmalonate semialdehyde dehydrogenase. It catalyses the irreversible oxidative decarboxylation of malonate semialdehyde and methylmalonate semialdehyde to acetyl-CoA and propionyl-CoA respectively. In doing so it participates in the catabolism of valine, thymine, and compounds catabolised by way of beta-alanine, including uracil and cytidine. The enzyme is located in the mitochondrion, and its activity links the valine and pyrimidine degradation pathways to central acyl-CoA metabolism.
The ALDH6A1 gene encodes a member of the aldehyde dehydrogenase protein family, and HGNC places it in the aldehyde dehydrogenases gene group. Its enzyme classification is EC 1.2.1.27. NCBI Gene notes that alternate splicing results in multiple transcript variants. Mouse and rat both carry an orthologous gene named Aldh6a1, which allows the enzyme to be studied in common rodent models.
The protein is also known as MMSDH, and the gene was previously named aldehyde dehydrogenase 6 family, member A1. Methylmalonate semialdehyde dehydrogenase deficiency is characterised by elevated beta-alanine, 3-hydroxypropionic acid, and both isomers of 3-amino and 3-hydroxyisobutyric acids in urine organic acids. This biochemical profile reflects the position of the enzyme at the end of the valine and pyrimidine catabolic routes, and makes ALDH6A1 a useful reference point for studies of these pathways.
ALDH6A1 is involved in the catabolism of valine, converting methylmalonate semialdehyde to propionyl-CoA, so it is a key enzyme for studying branched-chain amino acid breakdown.
The enzyme acts in pyrimidine catabolism, handling compounds processed via beta-alanine, including uracil and cytidine, as well as thymine.
Methylmalonate semialdehyde dehydrogenase deficiency produces a distinctive urinary organic acid profile, making ALDH6A1 relevant to research on inborn errors of metabolism.
As a mitochondrial member of the aldehyde dehydrogenase family, ALDH6A1 supports studies of how acyl-CoA products are generated within the organelle.
ALDH6A1 is a mitochondrial malonate and methylmalonate semialdehyde dehydrogenase. It catalyses the irreversible oxidative decarboxylation of these semialdehydes to acetyl-CoA and propionyl-CoA, contributing to the catabolism of valine, thymine, and beta-alanine-related compounds such as uracil and cytidine.
The official name is aldehyde dehydrogenase 6 family member A1, previously written as aldehyde dehydrogenase 6 family, member A1. The common alias is MMSDH, from methylmalonate semialdehyde dehydrogenase. UniProt lists the protein as methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase [acylating], mitochondrial. NCBI Gene reports multiple transcript variants from alternate splicing.
Mouse and rat both have an orthologous Aldh6a1 gene; check the datasheet of any product for its validated reactivity. Methylmalonate semialdehyde dehydrogenase deficiency is characterised by raised beta-alanine, 3-hydroxypropionic acid, and 3-amino and 3-hydroxyisobutyric acids in urine organic acids.
Other aldehyde dehydrogenase family members involved in metabolism and detoxification, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q02252; product specifications from Assay Genie datasheets.